Depression (Episode 3 of 4) - Advanced Treatments for Treatment-Resistant Depression | NEJM

Sdílet
Vložit
  • čas přidán 28. 05. 2024
  • In this third episode of a four-part Double Take video miniseries on depression
    from the New England Journal of Medicine, Drs. Sanacora, Nikayin, and Cristancho
    discuss the role neuroplasticity may play in the pathogenesis of depression and
    the benefits to patients of advanced therapies for treatment-resistant depression,
    such as electroconvulsive therapy and transcranial magnetic stimulation.
    An overview of emerging evidence for the use of ketamine, esketamine, and
    psilocybin as new or potential treatments is also examined.
    For further reading, the following articles, referenced in this video, are
    available at the Journal’s website: Esketamine for Treatment-Resistant Depression
    - First FDA-Approved Antidepressant in a New Class (Kim et al., in the July 4,
    2019, issue; www.nejm.org/doi/full/10.1056... ), Electroconvulsive Therapy (Espinoza and Kellner, in the February
    17, 2022, issue; www.nejm.org/doi/full/10.1056... ), Psilocybin in Treatment-Resistant Depression (Madras; www.nejm.org/doi/full/10.1056... ) and
    Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
    (Goodwin et al.; www.nejm.org/doi/full/10.1056... ) (both in the November 3, 2022, issue), Ketamine versus ECT for
    Nonpsychotic Treatment-Resistant Major Depression (Anand et al., in the June
    22, 2023, issue; www.nejm.org/doi/full/10.1056... ), and Esketamine Nasal Spray versus Quetiapine for Treatment
    -Resistant Depression (Reif et al., in the October 5, 2023, issue; www.nejm.org/doi/full/10.1056... ).
    #depression #depressionmanagement #mentalhealth #mentalillness #nejm
    The New England Journal of Medicine is the world’s leading general medical
    journal. Continuously published for over 200 years, the Journal publishes
    peer-reviewed research along with interactive clinical content for physicians,
    educators, and the global medical community at NEJM.org.
  • Věda a technologie

Komentáře • 3

  • @Omnis2
    @Omnis2 Před měsícem

    Is there some kind of listing or registry for psychiatrists or organizations that aren’t involved in pseudoscience or quackery? How do you know where to go to get legitimate help?

    • @adoptmeeverything
      @adoptmeeverything Před měsícem

      Would by verifying license with state medical board. They would also be able to tell if any doctor has been subject to disciplinary action.

  • @James-ke5sx
    @James-ke5sx Před 29 dny

    I'm 74 and have been smoking small amounts of marijuana since my twenties. It gets rid of depression with no side effects. And here in Canada it's legal. Problem solved Nature's Way.